Efficacy and safety of thalidomide and dexamethasone combination with or without cyclophosphamide in patients with newly diagnosed multiple myeloma

被引：0
|
作者：
Kim, Y.-K.
Lee, J. J.
Sohn, S. K.
Shin, H. J.
Lee, S. R.
Shim, H. J.
Ahn, J. S.
Kim, D. H.
Yang, D. H.
Cho, S. H.
Chung, I. J.
Kim, H. J.
机构：
[1] Chonnam Natl Univ, Hwasun Hosp, Jeollanam, South Korea
[2] Kyungpook Natl Univ Hosp, Taegu, South Korea
[3] Pusan Natl Univ Hosp, Pusan, South Korea
来源：
HAEMATOLOGICA-THE HEMATOLOGY JOURNAL | 2007年 / 92卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
1119
引用
收藏
页码：411 / 412
页数：2
相关论文
共 50 条
  • [1] Combination chemotherapy with cyclophosphamide, thalidomide and dexamethasone for patients with refractory, newly diagnosed or relapsed myeloma
    Sidra, Gamal
    Williams, Cathy D.
    Russell, Nigel H.
    Zaman, Sonya
    Myers, Bethan
    Byrne, Jennifer L.
    [J]. HAEMATOLOGICA, 2006, 91 (06) : 862 - 863
  • [2] Superiority of the triple combination of bortezomib, cyclophosphamide and dexamethasone versus cyclophosphamide, thalidomide and dexamethasone in patients with newly diagnosed multiple myeloma, eligible for transplantation
    Crusoe, Edvan De Queiroz
    Higashi, Fabiana
    Martinez, Gracia
    Bittencourt, Rosane
    Pinto Neto, Jorge Vaz
    Sousa, Lais
    Santucci, Rodrigo
    Pessoa Magalhaes, Roberto Jose
    Colli, Gilberto
    Marques Nunes, Renata Ferreira
    Ribeiro, Glaciano
    Nicacio, Jandir
    Zanella, Karla Richter
    Kutner, Jose Mauro
    Magalhaes, Andre
    Leao, Danielle
    Hallack Neto, Abrahao Elias
    Braga, Walter
    Souza, Emanuella G.
    Guimaraes, Antonio Julio A. M.
    Durigon, Giovanna Steffenello
    Laks, Dani
    Maiolino, Angelo
    de Moraes Hungria, Vania Tietsche
    [J]. HEMATOLOGY TRANSFUSION AND CELL THERAPY, 2020, 42 (02) : 118 - 124
  • [3] CYCLOPHOSPHAMIDE, THALIDOMIDE AND DEXAMETHASONE (CTD) AS INITIAL THERAPY FOR NEWLY DIAGNOSED MULTIPLE MYELOMA PATIENTS
    Vasquez, J.
    Ruiz, R.
    Aliaga, K.
    Valencia, F.
    Enriquez, D.
    Palacios, V.
    Quintana, S.
    Casanova, L.
    [J]. HAEMATOLOGICA, 2016, 101 : 798 - 798
  • [4] Safety and Efficacy of the Combination of Selinexor, Lenalidomide and Dexamethasone (SRd) in Patients with Newly Diagnosed Multiple Myeloma
    White, Darrell J.
    Lentzsch, Suzanne
    Gasparetto, Cristina
    Bahlis, Nizar
    Chen, Christine I.
    Lipe, Brea C.
    Schiller, Gary J.
    Tuchman, Sascha A.
    Sutherland, Heather J.
    Kotb, Rami
    Leblanc, Richard
    Sebag, Michael
    Venner, Christopher P.
    Callander, Natalie Scott
    Bensinger, William I.
    Sheehan, Heidi
    Chai, Yi
    Kai, Kazuharu
    Shah, Jatin
    Shacham, Sharon
    Kauffman, Michael G.
    Baljevic, Muhamed
    [J]. BLOOD, 2019, 134
  • [5] Cyclophosphamide, thalidomide and dexamethasone (CTD) as initial therapy for newly diagnosed multiple myeloma patients.
    Chavez, Jule Franve Vasquez
    Mendoza, Rossana Esther Ruiz
    Llerena, Karina Mayra Aliaga
    Valencia, Fernando
    Enriquez, Daniel
    Palacios, Victor
    Casanova, Luis
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [6] Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen
    Jung, Sung-Hoon
    Park, Hyungchul
    Ahn, Jae-Sook
    Yang, Deok-Hwan
    Kim, Mi-Young
    Kim, Yeo-Kyeoung
    Kim, Hyeoung-Joon
    Lee, Je-Jung
    [J]. INTERNATIONAL JOURNAL OF HEMATOLOGY, 2013, 97 (01) : 92 - 97
  • [7] Efficacy of stem cell mobilization in patients with newly diagnosed multiple myeloma after a CTD (cyclophosphamide, thalidomide, and dexamethasone) regimen
    Sung-Hoon Jung
    Hyungchul Park
    Jae-Sook Ahn
    Deok-Hwan Yang
    Mi-Young Kim
    Yeo-Kyeoung Kim
    Hyeoung-Joon Kim
    Je-Jung Lee
    [J]. International Journal of Hematology, 2013, 97 : 92 - 97
  • [8] Addition of bortezomib improves efficacy of thalidomide/dexamethasone in newly diagnosed patients with multiple myeloma
    不详
    [J]. CLINICAL LYMPHOMA & MYELOMA, 2008, 8 (02): : 78 - 79
  • [9] Subcutaneous Administration of Bortezomib in Combination with Thalidomide and Dexamethasone for Treatment of Newly Diagnosed Multiple Myeloma Patients
    Wu, Shenghao
    Zheng, Cuiping
    Chen, Songyan
    Cai, Xiaoping
    Shi, Yuejian
    Lin, Bijing
    Chen, Yuemiao
    [J]. BIOMED RESEARCH INTERNATIONAL, 2015, 2015
  • [10] Bortezomib in combination with dexamethasone and subsequent thalidomide for newly-diagnosed multiple myeloma in Chinese patients
    Cai, Zhen
    Zheng, Weiyan
    Wei, Guoqing
    Ye, Xiujin
    He, Jingsong
    Li, Li
    Wu, Wenjun
    Lin, Maofang
    [J]. BLOOD, 2007, 110 (11) : 281B - 281B
12345